% $ biblatex auxiliary file $
% $ biblatex bbl format version 2.8 $
% Do not modify the above lines!
%
% This is an auxiliary file used by the 'biblatex' package.
% This file may safely be deleted. It will be recreated as
% required.
%
\begingroup
\makeatletter
\@ifundefined{ver@biblatex.sty}
  {\@latex@error
     {Missing 'biblatex' package}
     {The bibliography requires the 'biblatex' package.}
      \aftergroup\endinput}
  {}
\endgroup

\sortlist[entry]{nyt/global/}
  \entry{Ambrosius2010}{article}{}
    \name{author}{2}{}{%
      {{hash=AWT}{%
         family={Ambrosius},
         familyi={A\bibinitperiod},
         given={Walter\bibnamedelima T.},
         giveni={W\bibinitperiod\bibinitdelim T\bibinitperiod},
      }}%
      {{hash=MJD}{%
         family={Mahnken},
         familyi={M\bibinitperiod},
         given={Jonathan\bibnamedelima D.},
         giveni={J\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{AWTMJD1}
    \strng{fullhash}{AWTMJD1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2010}
    \field{sortinit}{A}
    \field{sortinithash}{A}
    \verb{doi}
    \verb 10.1002/sim.3873
    \endverb
    \field{pages}{n/a\bibrangedash n/a}
    \field{title}{Power for studies with random group sizes}
    \verb{url}
    \verb https://doi.org/10.1002%2Fsim.3873
    \endverb
    \field{journaltitle}{Statistics in Medicine}
    \field{year}{2010}
  \endentry

  \entry{Avery2017}{article}{}
    \name{author}{8}{}{%
      {{hash=AKNL}{%
         family={Avery},
         familyi={A\bibinitperiod},
         given={Kerry N\bibnamedelima L},
         giveni={K\bibinitperiod\bibinitdelim N\bibinitperiod\bibinitdelim
  L\bibinitperiod},
      }}%
      {{hash=WPR}{%
         family={Williamson},
         familyi={W\bibinitperiod},
         given={Paula\bibnamedelima R},
         giveni={P\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=GC}{%
         family={Gamble},
         familyi={G\bibinitperiod},
         given={Carrol},
         giveni={C\bibinitperiod},
      }}%
      {{hash=FEO}{%
         family={Francischetto},
         familyi={F\bibinitperiod},
         given={Elaine\bibnamedelima O{\textquotesingle}Connell},
         giveni={E\bibinitperiod\bibinitdelim O\bibinitperiod},
      }}%
      {{hash=MC}{%
         family={Metcalfe},
         familyi={M\bibinitperiod},
         given={Chris},
         giveni={C\bibinitperiod},
      }}%
      {{hash=DP}{%
         family={Davidson},
         familyi={D\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
      {{hash=WH}{%
         family={Williams},
         familyi={W\bibinitperiod},
         given={Hywel},
         giveni={H\bibinitperiod},
      }}%
      {{hash=BJM}{%
         family={Blazeby},
         familyi={B\bibinitperiod},
         given={Jane\bibnamedelima M},
         giveni={J\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {{BMJ}}%
    }
    \strng{namehash}{AKNL+1}
    \strng{fullhash}{AKNLWPRGCFEOMCDPWHBJM1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2017}
    \field{sortinit}{A}
    \field{sortinithash}{A}
    \verb{doi}
    \verb 10.1136/bmjopen-2016-013537
    \endverb
    \field{number}{2}
    \field{pages}{e013537}
    \field{title}{Informing efficient randomised controlled trials: exploration
  of challenges in developing progression criteria for internal pilot studies}
    \verb{url}
    \verb https://doi.org/10.1136%2Fbmjopen-2016-013537
    \endverb
    \field{volume}{7}
    \field{journaltitle}{{BMJ} Open}
    \field{year}{2017}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Bacchetti2008}{article}{}
    \name{author}{3}{}{%
      {{hash=BP}{%
         family={Bacchetti},
         familyi={B\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
      {{hash=MCE}{%
         family={McCulloch},
         familyi={M\bibinitperiod},
         given={Charles\bibnamedelima E.},
         giveni={C\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=SMR}{%
         family={Segal},
         familyi={S\bibinitperiod},
         given={Mark\bibnamedelima R.},
         giveni={M\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{BPMCESMR1}
    \strng{fullhash}{BPMCESMR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2008}
    \field{sortinit}{B}
    \field{sortinithash}{B}
    \verb{doi}
    \verb 10.1111/j.1541-0420.2008.01004_1.x
    \endverb
    \field{number}{2}
    \field{pages}{577\bibrangedash 585}
    \field{title}{Simple, Defensible Sample Sizes Based on Cost Efficiency}
    \verb{url}
    \verb http://dx.doi.org/10.1111/j.1541-0420.2008.01004_1.x
    \endverb
    \field{volume}{64}
    \field{journaltitle}{Biometrics}
    \field{year}{2008}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Chen2011a}{article}{}
    \name{author}{5}{}{%
      {{hash=CMH}{%
         family={Chen},
         familyi={C\bibinitperiod},
         given={Ming-Hui},
         giveni={M\bibinitperiod-H\bibinitperiod},
      }}%
      {{hash=IJG}{%
         family={Ibrahim},
         familyi={I\bibinitperiod},
         given={Joseph\bibnamedelima G.},
         giveni={J\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=LP}{%
         family={Lam},
         familyi={L\bibinitperiod},
         given={Peter},
         giveni={P\bibinitperiod},
      }}%
      {{hash=YA}{%
         family={Yu},
         familyi={Y\bibinitperiod},
         given={Alan},
         giveni={A\bibinitperiod},
      }}%
      {{hash=ZY}{%
         family={Zhang},
         familyi={Z\bibinitperiod},
         given={Yuanye},
         giveni={Y\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{CMH+1}
    \strng{fullhash}{CMHIJGLPYAZY1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2011}
    \field{sortinit}{C}
    \field{sortinithash}{C}
    \verb{doi}
    \verb 10.1111/j.1541-0420.2011.01561.x
    \endverb
    \field{number}{3}
    \field{pages}{1163\bibrangedash 1170}
    \field{title}{Bayesian Design of Noninferiority Trials for Medical Devices
  Using Historical Data}
    \verb{url}
    \verb https://doi.org/10.1111%2Fj.1541-0420.2011.01561.x
    \endverb
    \field{volume}{67}
    \field{journaltitle}{Biometrics}
    \field{year}{2011}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{DeGroot1970}{book}{}
    \name{author}{1}{}{%
      {{hash=DMH}{%
         family={DeGroot},
         familyi={D\bibinitperiod},
         given={Morris\bibnamedelima H.},
         giveni={M\bibinitperiod\bibinitdelim H\bibinitperiod},
      }}%
    }
    \strng{namehash}{DMH1}
    \strng{fullhash}{DMH1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{1970}
    \field{sortinit}{D}
    \field{sortinithash}{D}
    \field{title}{Optimal Statistical Decisions}
    \field{year}{1970}
  \endentry

  \entry{Fay2006}{article}{}
    \name{author}{3}{}{%
      {{hash=FMP}{%
         family={Fay},
         familyi={F\bibinitperiod},
         given={Michael\bibnamedelima P.},
         giveni={M\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
      {{hash=HME}{%
         family={Halloran},
         familyi={H\bibinitperiod},
         given={M.\bibnamedelima Elizabeth},
         giveni={M\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=FDA}{%
         family={Follmann},
         familyi={F\bibinitperiod},
         given={Dean\bibnamedelima A.},
         giveni={D\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{FMPHMEFDA1}
    \strng{fullhash}{FMPHMEFDA1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2006}
    \field{sortinit}{F}
    \field{sortinithash}{F}
    \verb{doi}
    \verb 10.1111/j.1541-0420.2006.00703.x
    \endverb
    \field{number}{2}
    \field{pages}{465\bibrangedash 474}
    \field{title}{Accounting for Variability in Sample Size Estimation with
  Applications to Nonadherence and Estimation of Variance and Effect Size}
    \verb{url}
    \verb https://doi.org/10.1111%2Fj.1541-0420.2006.00703.x
    \endverb
    \field{volume}{63}
    \field{journaltitle}{Biometrics}
    \field{year}{2006}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Goette2015}{article}{}
    \name{author}{4}{}{%
      {{hash=GH}{%
         family={Götte},
         familyi={G\bibinitperiod},
         given={Heiko},
         giveni={H\bibinitperiod},
      }}%
      {{hash=SA}{%
         family={Schüler},
         familyi={S\bibinitperiod},
         given={Armin},
         giveni={A\bibinitperiod},
      }}%
      {{hash=KM}{%
         family={Kirchner},
         familyi={K\bibinitperiod},
         given={Marietta},
         giveni={M\bibinitperiod},
      }}%
      {{hash=KM}{%
         family={Kieser},
         familyi={K\bibinitperiod},
         given={Meinhard},
         giveni={M\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{GH+1}
    \strng{fullhash}{GHSAKMKM1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2015}
    \field{sortinit}{G}
    \field{sortinithash}{G}
    \verb{doi}
    \verb 10.1002/pst.1717
    \endverb
    \field{number}{6}
    \field{pages}{515\bibrangedash 524}
    \field{title}{Sample size planning for phase {II} trials based on success
  probabilities for phase {III}}
    \verb{url}
    \verb https://doi.org/10.1002%2Fpst.1717
    \endverb
    \field{volume}{14}
    \field{journaltitle}{Pharmaceutical Statistics}
    \field{year}{2015}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Hampson2017}{article}{}
    \name{author}{4}{}{%
      {{hash=HLV}{%
         family={Hampson},
         familyi={H\bibinitperiod},
         given={Lisa\bibnamedelima V},
         giveni={L\bibinitperiod\bibinitdelim V\bibinitperiod},
      }}%
      {{hash=WPR}{%
         family={Williamson},
         familyi={W\bibinitperiod},
         given={Paula\bibnamedelima R},
         giveni={P\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=WMJ}{%
         family={Wilby},
         familyi={W\bibinitperiod},
         given={Martin\bibnamedelima J},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=JT}{%
         family={Jaki},
         familyi={J\bibinitperiod},
         given={Thomas},
         giveni={T\bibinitperiod},
      }}%
    }
    \strng{namehash}{HLV+1}
    \strng{fullhash}{HLVWPRWMJJT1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2017}
    \field{sortinit}{H}
    \field{sortinithash}{H}
    \field{abstract}{%
    Just over half of publicly funded trials recruit their target sample size
  within the planned study duration. When recruitment targets are missed, the
  funder of a trial is faced with the decision of either committing further
  resources to the study or risk that a worthwhile treatment effect may be
  missed by an underpowered final analysis. To avoid this challenging
  situation, when there is insufficient prior evidence to support predicted
  recruitment rates, funders now require feasibility assessments to be
  performed in the early stages of trials. Progression criteria are usually
  specified and agreed with the funder ahead of time. To date, however, the
  progression rules used are typically ad hoc. In addition, rules routinely
  permit adaptations to recruitment strategies but do not stipulate criteria
  for evaluating their effectiveness. In this paper, we develop a framework for
  planning and designing internal pilot studies which permit a trial to be
  stopped early if recruitment is disappointing or to continue to full
  recruitment if enrolment during the feasibility phase is adequate. This
  framework enables a progression rule to be pre-specified and agreed upon
  prior to starting a trial. The novel two-stage designs stipulate that if
  neither of these situations arises, adaptations to recruitment should be made
  and subsequently evaluated to establish whether they have been successful. We
  derive optimal progression rules for internal pilot studies which minimise
  the expected trial overrun and maintain a high probability of completing the
  study when the recruitment rate is adequate. The advantages of this procedure
  are illustrated using a real trial example.%
    }
    \verb{doi}
    \verb 10.1177/0962280217708906
    \endverb
    \verb{eprint}
    \verb http://dx.doi.org/10.1177/0962280217708906
    \endverb
    \field{note}{PMID: 28589752}
    \field{number}{0}
    \field{pages}{0962280217708906}
    \field{title}{A framework for prospectively defining progression rules for
  internal pilot studies monitoring recruitment}
    \verb{url}
    \verb http://dx.doi.org/10.1177/0962280217708906
    \endverb
    \field{volume}{0}
    \field{journaltitle}{Statistical Methods in Medical Research}
    \field{year}{2017}
  \endentry

  \entry{Ibrahim2014}{article}{}
    \name{author}{5}{}{%
      {{hash=IJG}{%
         family={Ibrahim},
         familyi={I\bibinitperiod},
         given={Joseph\bibnamedelima G.},
         giveni={J\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
      {{hash=CMH}{%
         family={Chen},
         familyi={C\bibinitperiod},
         given={Ming-Hui},
         giveni={M\bibinitperiod-H\bibinitperiod},
      }}%
      {{hash=LM}{%
         family={Lakshminarayanan},
         familyi={L\bibinitperiod},
         given={Mani},
         giveni={M\bibinitperiod},
      }}%
      {{hash=LGF}{%
         family={Liu},
         familyi={L\bibinitperiod},
         given={Guanghan\bibnamedelima F.},
         giveni={G\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
      {{hash=HJF}{%
         family={Heyse},
         familyi={H\bibinitperiod},
         given={Joseph\bibnamedelima F.},
         giveni={J\bibinitperiod\bibinitdelim F\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{IJG+1}
    \strng{fullhash}{IJGCMHLMLGFHJF1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2014}
    \field{sortinit}{I}
    \field{sortinithash}{I}
    \verb{doi}
    \verb 10.1002/sim.6339
    \endverb
    \field{number}{2}
    \field{pages}{249\bibrangedash 264}
    \field{title}{Bayesian probability of success for clinical trials using
  historical data}
    \verb{url}
    \verb https://doi.org/10.1002%2Fsim.6339
    \endverb
    \field{volume}{34}
    \field{journaltitle}{Statistics in Medicine}
    \field{year}{2014}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Jiang2011}{article}{}
    \name{author}{1}{}{%
      {{hash=JK}{%
         family={Jiang},
         familyi={J\bibinitperiod},
         given={Kaihong},
         giveni={K\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Informa {UK} Limited}%
    }
    \strng{namehash}{JK1}
    \strng{fullhash}{JK1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2011}
    \field{sortinit}{J}
    \field{sortinithash}{J}
    \verb{doi}
    \verb 10.1198/sbr.2011.10068
    \endverb
    \field{number}{3}
    \field{pages}{463\bibrangedash 475}
    \field{title}{Optimal Sample Sizes and Go/No-Go Decisions for Phase
  {II}/{III} Development Programs Based on Probability of Success}
    \verb{url}
    \verb https://doi.org/10.1198%2Fsbr.2011.10068
    \endverb
    \field{volume}{3}
    \field{journaltitle}{Statistics in Biopharmaceutical Research}
    \field{year}{2011}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Julious2006}{article}{}
    \name{author}{2}{}{%
      {{hash=JSA}{%
         family={Julious},
         familyi={J\bibinitperiod},
         given={Steven\bibnamedelima A.},
         giveni={S\bibinitperiod\bibinitdelim A\bibinitperiod},
      }}%
      {{hash=ORJ}{%
         family={Owen},
         familyi={O\bibinitperiod},
         given={Roger\bibnamedelima J.},
         giveni={R\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{JSAORJ1}
    \strng{fullhash}{JSAORJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2006}
    \field{sortinit}{J}
    \field{sortinithash}{J}
    \verb{doi}
    \verb 10.1002/pst.197
    \endverb
    \field{number}{1}
    \field{pages}{29\bibrangedash 37}
    \field{title}{Sample size calculations for clinical studies allowing for
  uncertainty about the variance}
    \verb{url}
    \verb http://dx.doi.org/10.1002/pst.197
    \endverb
    \field{volume}{5}
    \field{journaltitle}{Pharmaceutical Statistics}
    \field{year}{2006}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Kirby2012}{article}{}
    \name{author}{4}{}{%
      {{hash=KS}{%
         family={Kirby},
         familyi={K\bibinitperiod},
         given={S},
         giveni={S},
      }}%
      {{hash=BJ}{%
         family={Burke},
         familyi={B\bibinitperiod},
         given={J},
         giveni={J},
      }}%
      {{hash=CSC}{%
         family={Chuang-Stein},
         familyi={C\bibinitperiod-S\bibinitperiod},
         given={C},
         giveni={C},
      }}%
      {{hash=SC}{%
         family={Sin},
         familyi={S\bibinitperiod},
         given={C},
         giveni={C},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley Online Library}%
    }
    \strng{namehash}{KS+1}
    \strng{fullhash}{KSBJCSCSC1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2012}
    \field{sortinit}{K}
    \field{sortinithash}{K}
    \verb{doi}
    \verb 10.1002/pst.1521
    \endverb
    \field{number}{5}
    \field{pages}{373\bibrangedash 385}
    \field{title}{Discounting phase 2 results when planning phase 3 clinical
  trials}
    \field{volume}{11}
    \field{journaltitle}{Pharmaceutical statistics}
    \field{year}{2012}
  \endentry

  \entry{Landau2013}{article}{}
    \name{author}{2}{}{%
      {{hash=LS}{%
         family={Landau},
         familyi={L\bibinitperiod},
         given={Sabine},
         giveni={S\bibinitperiod},
      }}%
      {{hash=SD}{%
         family={Stahl},
         familyi={S\bibinitperiod},
         given={Daniel},
         giveni={D\bibinitperiod},
      }}%
    }
    \strng{namehash}{LSSD1}
    \strng{fullhash}{LSSD1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2013}
    \field{sortinit}{L}
    \field{sortinithash}{L}
    \field{abstract}{%
    This paper shows how Monte Carlo simulation can be used for sample size,
  power or precision calculations when planning medical research studies.
  Standard study designs can lead to the use of analysis methods for which
  power formulae do not exist. This may be because complex modelling techniques
  with optimal statistical properties are used but power formulae have not yet
  been derived or because analysis models are employed that divert from the
  population model due to lack of availability of more appropriate analysis
  tools. Our presentation concentrates on the conceptual steps involved in
  carrying out power or precision calculations by simulation. We demonstrate
  these steps in three examples concerned with (i) drop out in longitudinal
  studies, (ii) measurement error in observational studies and (iii) causal
  effect estimation in randomised controlled trials with non-compliance. We
  conclude that the Monte Carlo simulation approach is an important general
  tool in the methodological arsenal for assessing power and precision.%
    }
    \verb{doi}
    \verb 10.1177/0962280212439578
    \endverb
    \verb{eprint}
    \verb http://smm.sagepub.com/content/22/3/324.full.pdf+html
    \endverb
    \field{number}{3}
    \field{pages}{324\bibrangedash 345}
    \field{title}{Sample size and power calculations for medical studies by
  simulation when closed form expressions are not available}
    \verb{url}
    \verb http://smm.sagepub.com/content/22/3/324.abstract
    \endverb
    \field{volume}{22}
    \field{journaltitle}{Statistical Methods in Medical Research}
    \field{year}{2013}
  \endentry

  \entry{Lindley1997}{article}{}
    \name{author}{1}{}{%
      {{hash=LDV}{%
         family={Lindley},
         familyi={L\bibinitperiod},
         given={Dennis\bibnamedelima V.},
         giveni={D\bibinitperiod\bibinitdelim V\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Blackwell Publishers Ltd}%
    }
    \keyw{Binomial sampling, Coherence, Coverage probabilities, Highest
  posterior density intervals, Information, Log-odds, Maximization of expected
  utility, Sample size determination}
    \strng{namehash}{LDV1}
    \strng{fullhash}{LDV1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{1997}
    \field{sortinit}{L}
    \field{sortinithash}{L}
    \verb{doi}
    \verb 10.1111/1467-9884.00068
    \endverb
    \field{issn}{1467-9884}
    \field{number}{2}
    \field{pages}{129\bibrangedash 138}
    \field{title}{The choice of sample size}
    \verb{url}
    \verb http://dx.doi.org/10.1111/1467-9884.00068
    \endverb
    \field{volume}{46}
    \field{journaltitle}{Journal of the Royal Statistical Society: Series D
  (The Statistician)}
    \field{year}{1997}
  \endentry

  \entry{OHagan2005}{article}{}
    \name{author}{3}{}{%
      {{hash=OA}{%
         family={O'Hagan},
         familyi={O\bibinitperiod},
         given={Anthony},
         giveni={A\bibinitperiod},
      }}%
      {{hash=SJW}{%
         family={Stevens},
         familyi={S\bibinitperiod},
         given={John\bibnamedelima W.},
         giveni={J\bibinitperiod\bibinitdelim W\bibinitperiod},
      }}%
      {{hash=CMJ}{%
         family={Campbell},
         familyi={C\bibinitperiod},
         given={Michael\bibnamedelima J.},
         giveni={M\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {John Wiley \& Sons, Ltd.}%
    }
    \keyw{assurance, Bayesian analysis, Bayesian clinical trial simulation,
  binary data, design of experiments, expected power, power, preposterior
  analysis, prior distribution, sample size}
    \strng{namehash}{OASJWCMJ1}
    \strng{fullhash}{OASJWCMJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2005}
    \field{sortinit}{O}
    \field{sortinithash}{O}
    \field{abstract}{%
    Conventional clinical trial design involves considerations of power, and
  sample size is typically chosen to achieve a desired power conditional on a
  specified treatment effect. In practice, there is considerable uncertainty
  about what the true underlying treatment effect may be, and so power does not
  give a good indication of the probability that the trial will demonstrate a
  positive outcome.Assurance is the unconditional probability that the trial
  will yield a âpositive outcomeâ. A positive outcome usually means a
  statistically significant result, according to some standard frequentist
  significance test. The assurance is then the prior expectation of the power,
  averaged over the prior distribution for the unknown true treatment effect.We
  argue that assurance is an important measure of the practical utility of a
  proposed trial, and indeed that it will often be appropriate to choose the
  size of the sample (and perhaps other aspects of the design) to achieve a
  desired assurance, rather than to achieve a desired power conditional on an
  assumed treatment effect. We extend the theory of assurance to two-sided
  testing and equivalence trials. We also show that assurance is
  straightforward to compute in some simple problems of normal, binary and
  gamma distributed data, and that the method is not restricted to simple
  conjugate prior distributions for parameters. Several illustrations are
  given. Copyright Â© 2005 John Wiley & Sons, Ltd.%
    }
    \verb{doi}
    \verb 10.1002/pst.175
    \endverb
    \field{issn}{1539-1612}
    \field{number}{3}
    \field{pages}{187\bibrangedash 201}
    \field{title}{Assurance in clinical trial design}
    \verb{url}
    \verb http://dx.doi.org/10.1002/pst.175
    \endverb
    \field{volume}{4}
    \field{journaltitle}{Pharmaceutical Statistics}
    \field{year}{2005}
  \endentry

  \entry{Patel2013}{article}{}
    \name{author}{4}{}{%
      {{hash=PNR}{%
         family={Patel},
         familyi={P\bibinitperiod},
         given={Nitin\bibnamedelima R},
         giveni={N\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=AS}{%
         family={Ankolekar},
         familyi={A\bibinitperiod},
         given={Suresh},
         giveni={S\bibinitperiod},
      }}%
      {{hash=AZ}{%
         family={Antonijevic},
         familyi={A\bibinitperiod},
         given={Zoran},
         giveni={Z\bibinitperiod},
      }}%
      {{hash=RN}{%
         family={Rajicic},
         familyi={R\bibinitperiod},
         given={Natasa},
         giveni={N\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley Online Library}%
    }
    \strng{namehash}{PNR+1}
    \strng{fullhash}{PNRASAZRN1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2013}
    \field{sortinit}{P}
    \field{sortinithash}{P}
    \verb{doi}
    \verb 10.1002/sim.5731
    \endverb
    \field{number}{10}
    \field{pages}{1763\bibrangedash 1777}
    \field{title}{A mathematical model for maximizing the value of phase 3 drug
  development portfolios incorporating budget constraints and risk}
    \field{volume}{32}
    \field{journaltitle}{Statistics in medicine}
    \field{year}{2013}
  \endentry

  \entry{Ren2013}{article}{}
    \name{author}{2}{}{%
      {{hash=RS}{%
         family={Ren},
         familyi={R\bibinitperiod},
         given={Shijie},
         giveni={S\bibinitperiod},
      }}%
      {{hash=OJE}{%
         family={Oakley},
         familyi={O\bibinitperiod},
         given={Jeremy\bibnamedelima E.},
         giveni={J\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{RSOJE1}
    \strng{fullhash}{RSOJE1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2013}
    \field{sortinit}{R}
    \field{sortinithash}{R}
    \verb{doi}
    \verb 10.1002/sim.5916
    \endverb
    \field{number}{1}
    \field{pages}{31\bibrangedash 45}
    \field{title}{Assurance calculations for planning clinical trials with
  time-to-event outcomes}
    \verb{url}
    \verb https://doi.org/10.1002%2Fsim.5916
    \endverb
    \field{volume}{33}
    \field{journaltitle}{Statistics in Medicine}
    \field{year}{2013}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Spiegelhalter2004}{book}{}
    \name{author}{3}{}{%
      {{hash=SDJ}{%
         family={Spiegelhalter},
         familyi={S\bibinitperiod},
         given={David\bibnamedelima J.},
         giveni={D\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=AKR}{%
         family={Abrams},
         familyi={A\bibinitperiod},
         given={Keith\bibnamedelima R.},
         giveni={K\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=MJP}{%
         family={Myles},
         familyi={M\bibinitperiod},
         given={Jonathan\bibnamedelima P.},
         giveni={J\bibinitperiod\bibinitdelim P\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley}%
    }
    \strng{namehash}{SDJAKRMJP1}
    \strng{fullhash}{SDJAKRMJP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2004}
    \field{sortinit}{S}
    \field{sortinithash}{S}
    \field{title}{Bayesian Approaches to Clinical Trials and Health-Care
  Evaluation}
    \field{year}{2004}
  \endentry

  \entry{Stallard2012}{article}{}
    \name{author}{1}{}{%
      {{hash=SN}{%
         family={Stallard},
         familyi={S\bibinitperiod},
         given={Nigel},
         giveni={N\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {John Wiley \& Sons, Ltd}%
    }
    \keyw{adaptive programmes of clinical development, Bayesian decision
  theory, clinical trial design}
    \strng{namehash}{SN1}
    \strng{fullhash}{SN1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2012}
    \field{sortinit}{S}
    \field{sortinithash}{S}
    \verb{doi}
    \verb 10.1002/sim.4357
    \endverb
    \field{issn}{1097-0258}
    \field{number}{11-12}
    \field{pages}{1031\bibrangedash 1042}
    \field{title}{Optimal sample sizes for phase {II} clinical trials and pilot
  studies}
    \verb{url}
    \verb http://dx.doi.org/10.1002/sim.4357
    \endverb
    \field{volume}{31}
    \field{journaltitle}{Statistics in Medicine}
    \field{year}{2012}
  \endentry

  \entry{Strong2015}{article}{}
    \name{author}{4}{}{%
      {{hash=SM}{%
         family={Strong},
         familyi={S\bibinitperiod},
         given={Mark},
         giveni={M\bibinitperiod},
      }}%
      {{hash=OJE}{%
         family={Oakley},
         familyi={O\bibinitperiod},
         given={Jeremy\bibnamedelima E},
         giveni={J\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
      {{hash=BA}{%
         family={Brennan},
         familyi={B\bibinitperiod},
         given={Alan},
         giveni={A\bibinitperiod},
      }}%
      {{hash=BP}{%
         family={Breeze},
         familyi={B\bibinitperiod},
         given={Penny},
         giveni={P\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {SAGE Publications Sage CA: Los Angeles, CA}%
    }
    \strng{namehash}{SM+1}
    \strng{fullhash}{SMOJEBABP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2015}
    \field{sortinit}{S}
    \field{sortinithash}{S}
    \field{number}{5}
    \field{pages}{570\bibrangedash 583}
    \field{title}{Estimating the expected value of sample information using the
  probabilistic sensitivity analysis sample: a fast, nonparametric
  regression-based method}
    \field{volume}{35}
    \field{journaltitle}{Medical Decision Making}
    \field{year}{2015}
  \endentry

  \entry{Sutton2007}{article}{}
    \name{author}{6}{}{%
      {{hash=SAJ}{%
         family={Sutton},
         familyi={S\bibinitperiod},
         given={Alexander\bibnamedelima J.},
         giveni={A\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=CNJ}{%
         family={Cooper},
         familyi={C\bibinitperiod},
         given={Nicola\bibnamedelima J.},
         giveni={N\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=JDR}{%
         family={Jones},
         familyi={J\bibinitperiod},
         given={David\bibnamedelima R.},
         giveni={D\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=LPC}{%
         family={Lambert},
         familyi={L\bibinitperiod},
         given={Paul\bibnamedelima C.},
         giveni={P\bibinitperiod\bibinitdelim C\bibinitperiod},
      }}%
      {{hash=TJR}{%
         family={Thompson},
         familyi={T\bibinitperiod},
         given={John\bibnamedelima R.},
         giveni={J\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
      {{hash=AKR}{%
         family={Abrams},
         familyi={A\bibinitperiod},
         given={Keith\bibnamedelima R.},
         giveni={K\bibinitperiod\bibinitdelim R\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{SAJ+1}
    \strng{fullhash}{SAJCNJJDRLPCTJRAKR1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2007}
    \field{sortinit}{S}
    \field{sortinithash}{S}
    \verb{doi}
    \verb 10.1002/sim.2704
    \endverb
    \field{number}{12}
    \field{pages}{2479\bibrangedash 2500}
    \field{title}{Evidence-based sample size calculations based upon updated
  meta-analysis}
    \verb{url}
    \verb https://doi.org/10.1002%2Fsim.2704
    \endverb
    \field{volume}{26}
    \field{journaltitle}{Statistics in Medicine}
    \field{year}{2007}
  \endentry

  \entry{Turner2004}{article}{}
    \name{author}{3}{}{%
      {{hash=TRM}{%
         family={Turner},
         familyi={T\bibinitperiod},
         given={Rebecca\bibnamedelima M.},
         giveni={R\bibinitperiod\bibinitdelim M\bibinitperiod},
      }}%
      {{hash=TPA}{%
         family={Toby\bibnamedelima Prevost},
         familyi={T\bibinitperiod\bibinitdelim P\bibinitperiod},
         given={A.},
         giveni={A\bibinitperiod},
      }}%
      {{hash=TSG}{%
         family={Thompson},
         familyi={T\bibinitperiod},
         given={Simon\bibnamedelima G.},
         giveni={S\bibinitperiod\bibinitdelim G\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {John Wiley \& Sons, Ltd.}%
    }
    \keyw{intracluster correlation coefficient, cluster randomized trials,
  sample size, power, Bayesian methods, study design}
    \strng{namehash}{TRMTPATSG1}
    \strng{fullhash}{TRMTPATSG1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2004}
    \field{sortinit}{T}
    \field{sortinithash}{T}
    \field{abstract}{%
    The sample size required for a cluster randomized trial depends on the
  magnitude of the intracluster correlation coefficient (ICC). The usual sample
  size calculation makes no allowance for the fact that the ICC is not known
  precisely in advance. We develop methods which allow for the uncertainty in a
  previously observed ICC, using a variety of distributional assumptions.
  Distributions for the power are derived, reflecting this uncertainty.
  Further, the observed ICC in a future study will not equal its true value,
  and we consider the impact of this on power. We implement calculations within
  a Bayesian simulation approach, and provide one simplification that can be
  performed using simple simulation within spreadsheet software. In our
  examples, recognizing the uncertainty in a previous ICC estimate decreases
  expected power, especially when the power calculated naively from the ICC
  estimate is high. To protect against the possibility of low power, sample
  sizes may need to be very substantially increased. Recognizing the
  variability in the future observed ICC has little effect if prior uncertainty
  has already been taken into account. We show how our method can be extended
  to the case in which multiple prior ICC estimates are available. The methods
  presented in this paper can be used by applied researchers to protect against
  loss of power, or to choose a design which reduces the impact of uncertainty
  in the ICC. Copyright Â© 2004 John Wiley & Sons, Ltd.%
    }
    \verb{doi}
    \verb 10.1002/sim.1721
    \endverb
    \field{issn}{1097-0258}
    \field{number}{8}
    \field{pages}{1195\bibrangedash 1214}
    \field{title}{Allowing for imprecision of the intracluster correlation
  coefficient in the design of cluster randomized trials}
    \verb{url}
    \verb http://dx.doi.org/10.1002/sim.1721
    \endverb
    \field{volume}{23}
    \field{journaltitle}{Statistics in Medicine}
    \field{year}{2004}
  \endentry

  \entry{Walley2015}{article}{}
    \name{author}{4}{}{%
      {{hash=WRJ}{%
         family={Walley},
         familyi={W\bibinitperiod},
         given={Rosalind\bibnamedelima J.},
         giveni={R\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
      {{hash=SCL}{%
         family={Smith},
         familyi={S\bibinitperiod},
         given={Claire\bibnamedelima L.},
         giveni={C\bibinitperiod\bibinitdelim L\bibinitperiod},
      }}%
      {{hash=GJD}{%
         family={Gale},
         familyi={G\bibinitperiod},
         given={Jeremy\bibnamedelima D.},
         giveni={J\bibinitperiod\bibinitdelim D\bibinitperiod},
      }}%
      {{hash=WP}{%
         family={Woodward},
         familyi={W\bibinitperiod},
         given={Phil},
         giveni={P\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{WRJ+1}
    \strng{fullhash}{WRJSCLGJDWP1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2015}
    \field{sortinit}{W}
    \field{sortinithash}{W}
    \verb{doi}
    \verb 10.1002/pst.1675
    \endverb
    \field{number}{3}
    \field{pages}{205\bibrangedash 215}
    \field{title}{Advantages of a wholly Bayesian approach to assessing
  efficacy in early drug development: a case study}
    \verb{url}
    \verb http://dx.doi.org/10.1002/pst.1675
    \endverb
    \field{volume}{14}
    \field{journaltitle}{Pharmaceutical Statistics}
    \field{year}{2015}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Wang2002}{article}{}
    \name{author}{2}{}{%
      {{hash=WF}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={Fei},
         giveni={F\bibinitperiod},
      }}%
      {{hash=GAE}{%
         family={Gelfand},
         familyi={G\bibinitperiod},
         given={Alan\bibnamedelima E.},
         giveni={A\bibinitperiod\bibinitdelim E\bibinitperiod},
      }}%
    }
    \list{language}{1}{%
      {English}%
    }
    \list{publisher}{1}{%
      {Institute of Mathematical Statistics}%
    }
    \strng{namehash}{WFGAE1}
    \strng{fullhash}{WFGAE1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2002}
    \field{sortinit}{W}
    \field{sortinithash}{W}
    \field{abstract}{%
    Sample size determination (SSD) is a crucial aspect of experimental design.
  Two SSD problems are considered here. The first concerns how to select a
  sample size to achieve specified performance with regard to one or more
  features of a model. Adopting a Bayesian perspective, we move the Bayesian
  SSD problem from the rather elementary models addressed in the literature to
  date in the direction of the wide range of hierarchical models which dominate
  the current Bayesian landscape. Our approach is generic and thus, in
  principle, broadly applicable. However, it requires full model specification
  and computationally intensive simulation, perhaps limiting it practically to
  simple instances of such models. Still, insight from such cases is of useful
  design value. In addition, we present some theoretical tools for studying
  performance as a function of sample size, with a variety of illustrative
  results. Such results provide guidance with regard to what is achievable. We
  also offer two examples, a survival model with censoring and a logistic
  regression model. The second problem concerns how to select a sample size to
  achieve specified separation of two models. We approach this problem by
  adopting a screening criterion which in turn forms a model choice criterion.
  This criterion is set up to choose model 1 when the value is large, model 2
  when the value is small. The SSD problem then requires choosing n<sub>1</sub>
  to make the probability of selecting model 1 when model 1 is true
  sufficiently large and choosing n<sub>2</sub> to make the probability of
  selecting model 2 when model 2 is true sufficiently large. The required n is
  max (n<sub>1</sub>, n<sub>2</sub>). Here, we again provide two illustrations.
  One considers separating normal errors from t errors, the other separating a
  common growth curve model from a model with individual growth curves.%
    }
    \field{issn}{08834237}
    \field{number}{2}
    \field{pages}{pp. 193\bibrangedash 208}
    \field{title}{A Simulation-Based Approach to Bayesian Sample Size
  Determination for Performance under a Given Model and for Separating Models}
    \verb{url}
    \verb http://www.jstor.org/stable/3182824
    \endverb
    \field{volume}{17}
    \field{journaltitle}{Statistical Science}
    \field{year}{2002}
  \endentry

  \entry{Wang2013}{article}{}
    \name{author}{4}{}{%
      {{hash=WY}{%
         family={Wang},
         familyi={W\bibinitperiod},
         given={Yanping},
         giveni={Y\bibinitperiod},
      }}%
      {{hash=FH}{%
         family={Fu},
         familyi={F\bibinitperiod},
         given={Haoda},
         giveni={H\bibinitperiod},
      }}%
      {{hash=KP}{%
         family={Kulkarni},
         familyi={K\bibinitperiod},
         given={Pandurang},
         giveni={P\bibinitperiod},
      }}%
      {{hash=KC}{%
         family={Kaiser},
         familyi={K\bibinitperiod},
         given={Christopher},
         giveni={C\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {{SAGE} Publications}%
    }
    \strng{namehash}{WY+1}
    \strng{fullhash}{WYFHKPKC1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2013}
    \field{sortinit}{W}
    \field{sortinithash}{W}
    \verb{doi}
    \verb 10.1177/1740774513478229
    \endverb
    \field{number}{3}
    \field{pages}{407\bibrangedash 413}
    \field{title}{Evaluating and utilizing probability of study success in
  clinical development}
    \verb{url}
    \verb https://doi.org/10.1177%2F1740774513478229
    \endverb
    \field{volume}{10}
    \field{journaltitle}{Clinical Trials}
    \field{year}{2013}
    \warn{\item Invalid format of field 'month'}
  \endentry

  \entry{Zhang2013}{article}{}
    \name{author}{2}{}{%
      {{hash=ZJ}{%
         family={Zhang},
         familyi={Z\bibinitperiod},
         given={Jianliang},
         giveni={J\bibinitperiod},
      }}%
      {{hash=ZJJ}{%
         family={Zhang},
         familyi={Z\bibinitperiod},
         given={Jenny\bibnamedelima J.},
         giveni={J\bibinitperiod\bibinitdelim J\bibinitperiod},
      }}%
    }
    \list{publisher}{1}{%
      {Wiley-Blackwell}%
    }
    \strng{namehash}{ZJZJJ1}
    \strng{fullhash}{ZJZJJ1}
    \field{labelnamesource}{author}
    \field{labeltitlesource}{title}
    \field{labelyear}{2013}
    \field{sortinit}{Z}
    \field{sortinithash}{Z}
    \verb{doi}
    \verb 10.1002/pst.1597
    \endverb
    \field{number}{6}
    \field{pages}{358\bibrangedash 365}
    \field{title}{Joint probability of statistical success of multiple phase
  {III} trials}
    \verb{url}
    \verb https://doi.org/10.1002%2Fpst.1597
    \endverb
    \field{volume}{12}
    \field{journaltitle}{Pharmaceutical Statistics}
    \field{year}{2013}
    \warn{\item Invalid format of field 'month'}
  \endentry
\endsortlist
\endinput
